SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

T. Rowe Price Investment Management, Inc.'s Holding History (CIK: 0001897612)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 85,511 Value ($000) $2 Avg Close $20.66 Range $17.34 - $25.07
Q2 2024
Shares 283,827 Value ($000) $6 Avg Close $20.93 Range $18.65 - $24.38
Q1 2024
Shares 2,459,235 Value ($000) $59 Avg Close $22.30 Range $19.58 - $25.34
Q4 2023
Shares 2,711,253 Value ($000) $59 Avg Close $15.37 Range $11.21 - $21.84
Q3 2023
Shares 1,066,548 Value ($000) $15 Avg Close $18.92 Range $12.85 - $23.55
Q2 2023
Shares 1,066,548 Value ($000) $22 Avg Close $20.82 Range $19.27 - $23.14
Q1 2023
Shares 1,000,715 Value ($000) $21 Avg Close $24.88 Range $20.01 - $29.86
Q4 2022
Shares 1,002,886 Value ($000) $26 Avg Close $23.32 Range $20.25 - $26.51
Q3 2022
Shares 923,226 Value ($000) $22,186 Avg Close $22.44 Range $18.05 - $25.71